Lasa Supergenerics Ltd
Wed 21/05/2025,16:11:46 | NSE : LASA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 17.05
Previous Close
₹ 17.03
Volume
414742
Mkt Cap ( Rs. Cr)
₹80.51
High
₹ 17.70
Low
₹ 15.56
52 Week High
₹ 33.49
52 Week Low
₹ 16.56
Book Value Per Share
₹ 19.30
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Lasa Supergenerics Ltd
Your Vote -
Buy
26.92%
Hold
3.85%
Sell
69.23%
26.92%
26 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
16.07
14
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
14
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Lasa Supergenerics - Strikes/Lockouts/Disturbances
-
Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Strikes /Lockouts / Disturbances
-
Lasa Supergenerics - Board Meeting Intimation
-
Lasa Supergenerics - Board Meeting Intimation for The Quarter And The Year Ended March 31, 2025
-
Lasa Supergenerics - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Lasa Supergenerics - Cessation
-
Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Lasa Supergenerics - General Updates
-
Lasa Supergenerics - Press Release
-
Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Lasa Supergenerics - Disclosure under SEBI Takeover Regulations
-
Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Lasa Supergenerics - General Updates
-
Lasa Supergenerics - Declaration With Respect To Non- Applicabitlity Of Large Entity
-
Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Lasa Supergenerics - Trading Window-XBRL
-
Lasa Supergenerics - Trading Window
-
Lasa Supergenerics - Integrated Filing (Financial)
-
Lasa Supergenerics - Shareholders meeting
-
Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Lasa Supergenerics - Shareholders meeting
-
Lasa Supergenerics to start trial runs from Nov 25
Key fundamentals
Evaluate the intrinsic value of Lasa Supergenerics Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 96.6762 | 118.2859 | 148.6341 | 158.9171 | 175.9458 |
| Liabilities | 96.6762 | 118.2859 | 148.6341 | 158.9171 | 175.9458 |
| Equity | 50.1012 | 50.1012 | 40.6727 | 40.6727 | 40.6727 |
| Gross Profit | 2.1658 | -6.5935 | 15.6327 | 47.221 | 29.948 |
| Net Profit | -21.7306 | -38.6207 | -5.3672 | 22.7777 | 3.6284 |
| Cash From Operating Activities | 2.1387 | -17.3004 | 10.4898 | 41.3103 | 13.6224 |
| NPM(%) | -20.82 | -29.8 | -3.91 | 11.25 | 2.16 |
| Revenue | 104.335 | 129.5678 | 137.1267 | 202.3795 | 167.2712 |
| Expenses | 102.1692 | 136.1613 | 121.494 | 155.1585 | 137.3232 |
| ROE(%) | -22.47 | -39.94 | -5.55 | 23.56 | 3.75 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 16 Sep 2022 | 0.25 | 2.5 | 0 | 62.35 |
| 15 Sep 2021 | 0.25 | 2.5 | 0 | 73.6 |
Peers
Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Sharda Cropchem Ltd | 631.20 | 2.44 | 18.71 | 154.28 | 337.37 | 1.43 |
| Amines and Plasticizers Ltd | 220.88 | 0.54 | 29.53 | 94.08 | 361.94 | 0.23 |
| Grauer and Weil (India) Ltd | 115.60 | 0.00 | 32.66 | 387.67 | 322.62 | 0.43 |
| HP Adhesives Ltd | 51.09 | -1.37 | 25.67 | 157.11 | 99.28 | 0.00 |
Company Info
Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.
Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.
Read More
Parent Organisation
Lasa Supergenerics Ltd.
Founded
11/11/2016
Managing Director
Dr.Omkar Pravin Herlekar
NSE Symbol
LASAEQ
FAQ
The current price of Lasa Supergenerics Ltd is ₹ 16.07.
The 52-week high for Lasa Supergenerics Ltd is ₹ 17.70 and the 52-week low is ₹ 15.56.
The market capitalization of Lasa Supergenerics Ltd is currently ₹ 80.51. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.
The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
